Who
Phillip P. Chan
Chief Executive Officer
Company insider
Files Form 4 as: Chief Executive Officer, Cytosorbents.
In numbers
- Trades disclosed
- 112
- Buys
- 20
- Sells
- 4
- Bought
- $892K
- Sold
- $395K
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 31 Dec 2008
- Last trade
- 15 Sep 2026
- Last filed
- 16 Sep 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 15 Sep 2026filed 16 Sep 2026 | CTSO CytosorbentsMedical Devices | SEC FORM 4 Bought | $23K3,774 at $6.00 | filing |
| 15 Sep 2026filed 16 Sep 2026 | CTSO CytosorbentsMedical Devices | SEC FORM 4 Bought | $23K3,774 at $6.00 | filing |
| 4 Sep 2026filed 9 Sep 2026 | CTSO CytosorbentsMedical Devices | SEC FORM 4 Bought | $70K200,000 at $0.35 | filing |
| 4 Sep 2026filed 9 Sep 2026 | CTSO CytosorbentsMedical Devices | SEC FORM 4 Bought | $70K200,000 at $0.35 | filing |
| 15 Jun 2026filed 15 Jun 2026 | CTSO CytosorbentsMedical Devices | SEC FORM 4 Bought | $4,44310,333 at $0.43 | filing |
| 15 Jun 2026filed 15 Jun 2026 | CTSO CytosorbentsMedical Devices | SEC FORM 4 Bought | $4,44310,333 at $0.43 | filing |
| 12 Jun 2026filed 15 Jun 2026 | CTSO CytosorbentsMedical Devices | SEC FORM 4 Bought | $100K251,136 at $0.40 | filing |
| 12 Jun 2026filed 15 Jun 2026 | CTSO CytosorbentsMedical Devices | SEC FORM 4 Bought | $100K251,136 at $0.40 | filing |
| 18 Nov 2025filed 20 Nov 2025 | CTSO CytosorbentsMedical Devices | SEC FORM 4 Code A | $64K100,000 at $0.64 | filing |
| 8 Aug 2025filed 8 Aug 2025 | CTSO Cytosorbentsoption or derivative · Medical Devices | SEC FORM 4 Code A | —136,400 at $0.00 | filing |
| 8 Aug 2025filed 8 Aug 2025 | CTSO CytosorbentsMedical Devices | SEC FORM 4 Code A | —105,600 at $0.00 | filing |
| 24 Feb 2025filed 26 Feb 2025 | CTSO Cytosorbentsoption or derivative · Medical Devices | SEC FORM 4 Code O | $39K34,168 at $1.13 | filing |
| 24 Feb 2025filed 26 Feb 2025 | CTSO CytosorbentsMedical Devices | SEC FORM 4 Code O | $39K34,168 at $1.13 | filing |
| 17 Jan 2025filed 22 Jan 2025 | CTSO Cytosorbentsoption or derivative · Medical Devices | SEC FORM 4 Code X | —90,832 at $0.00 | filing |
| 17 Jan 2025filed 22 Jan 2025 | CTSO Cytosorbentsoption or derivative · Medical Devices | SEC FORM 4 Code J | —90,832 | filing |
| 17 Jan 2025filed 22 Jan 2025 | CTSO Cytosorbentsoption or derivative · Medical Devices | SEC FORM 4 Code J | —90,832 | filing |
| 17 Jan 2025filed 22 Jan 2025 | CTSO CytosorbentsMedical Devices | SEC FORM 4 Code X | $91K90,832 at $1.00 | filing |
| 2 Apr 2024filed 4 Apr 2024 | CTSO Cytosorbentsoption or derivative · Medical Devices | SEC FORM 4 Code A | —124,000 | filing |
| 2 Apr 2024filed 4 Apr 2024 | CTSO CytosorbentsMedical Devices | SEC FORM 4 Code A | —96,000 at $0.00 | filing |
| 29 Mar 2024filed 2 Apr 2024 | CTSO Cytosorbentsoption or derivative · Medical Devices | SEC FORM 4 Code A | —129,998 | filing |
News
Critical Survey: Cytosorbents (NASDAQ:CTSO) & Trinity Biotech (NASDAQ:TRIB)CTSO · dailypolitical.com · 13 Oct 2026
0 headlines in the last 90 days name Phillip P. Chan; 1 article from the last 14 days about the 1 company they traded most, at most three about any one of them.